Literature DB >> 2153714

Angiotensin converting enzyme in the human basal forebrain and midbrain visualized by in vitro autoradiography.

S Y Chai1, J S McKenzie, M J McKinley, F A Mendelsohn.   

Abstract

angiotensin converting enzyme converts angiotensin I to angiotensin II, a peptide that plays an important role in the central regulation of blood pressure and fluid and electrolyte homeostasis. However, the distribution of this enzyme in the human brain has not been well described. In this study, angiotensin converting enzyme was mapped in the human basal forebrain and midbrain by using quantitative in vitro autoradiography employing a derivative of a potent converting enzyme inhibitor, 125I-351A, as radioligand. This radioligand binds specifically and with high affinity to angiotensin converting enzyme and also exhibited these properties in binding to slide-mounted sections of human basal ganglia. In the basal ganglia, high levels of binding of 125I-351A are found in the caudate nucleus, putamen, nucleus accumbens, both divisions of the globus pallidus, and substantia nigra pars reticulata. High densities of labelling also occur in the ventral pallidum. In the hypothalamus, a moderate level occurs in the paraventricular and supraoptic nuclei, and a diffuse, low level of binding is found throughout the periventricular region. The organum vasculosum of the lamina terminalis, one of the circumventricular organs, displays the highest concentration of binding. The choroid plexus contains only moderate density of labelling in contrast to other mammalian species previously studied. Major fibre tracts are devoid of activity except for the posterior limb of the internal capsule, which contains fascicles of intense activity. In the midbrain, a moderate density of binding is detected in the periaqueductal gray. The dorsal, central linear, and, more caudally, the centralis superior medialis raphe nuclei also contain moderate densities of labelling. Angiotensin converting enzyme is heterogeneously distributed in the caudate nucleus and putamen, with distinct patches of high concentration surrounded by a matrix of diffuse, lower levels. In the caudate nucleus, these patches of high binding corresponded to striosomes since they register with acetylcholinesterase-poor zones. The high concentration of angiotensin converting enzyme found in the basal ganglia suggests that the enzyme may be involved in processing neuropeptides that occur in high concentrations in these structures. Possible substrates for converting enzyme include not only angiotensin I but also substance P and enkephalins, which are also concentrated in striosomes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153714     DOI: 10.1002/cne.902910203

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  10 in total

Review 1.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

2.  Association between a functional polymorphism in the renin-angiotensin system and completed suicide.

Authors:  A Hishimoto; O Shirakawa; N Nishiguchi; T Hashimoto; M Yanagi; H Nushida; Y Ueno; K Maeda
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

3.  Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease.

Authors:  R Alvarez; V Alvarez; C H Lahoz; C Martínez; J Peña; J M Sánchez; L M Guisasola; J Salas-Puig; G Morís; J A Vidal; R Ribacoba; B B Menes; D Uría; E Coto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-12       Impact factor: 10.154

4.  Increased (pro)renin receptor expression in the subfornical organ of hypertensive humans.

Authors:  Silvana G Cooper; Darshan P Trivedi; Rieko Yamamoto; Caleb J Worker; Cheng-Yuan Feng; Jacob T Sorensen; Wei Yang; Zhenggang Xiong; Yumei Feng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-12-22       Impact factor: 4.733

Review 5.  Molecular evidence of tissue renin-angiotensin systems: a focus on the brain.

Authors:  Koji Sakai; Curt D Sigmund
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

6.  Angiotensin II regulates ACE and ACE2 in neurons through p38 mitogen-activated protein kinase and extracellular signal-regulated kinase 1/2 signaling.

Authors:  Liang Xiao; Karla K V Haack; Irving H Zucker
Journal:  Am J Physiol Cell Physiol       Date:  2013-03-27       Impact factor: 4.249

7.  Importance of the brain Angiotensin system in Parkinson's disease.

Authors:  John W Wright; Joseph W Harding
Journal:  Parkinsons Dis       Date:  2012-11-07

8.  Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study.

Authors:  Christopher D Verrico; Colin N Haile; Richard De La Garza; Kenneth Grasing; Thomas R Kosten; Thomas F Newton
Journal:  Int J Neuropsychopharmacol       Date:  2016-07-05       Impact factor: 5.176

Review 9.  A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases.

Authors:  John W Wright; Leen H Kawas; Joseph W Harding
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-25       Impact factor: 5.555

Review 10.  The counter regulatory axis of the renin angiotensin system in the brain and ischaemic stroke: Insight from preclinical stroke studies and therapeutic potential.

Authors:  Aisling McFall; Stuart A Nicklin; Lorraine M Work
Journal:  Cell Signal       Date:  2020-10-13       Impact factor: 4.315

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.